Trial Summary
What is the purpose of this trial?
Objectives: Primary Aim: Examine the feasibility of a dyadic yoga program in 40 Head and Neck Cancer (HNC) patients undergoing radiotherapy (RT) and their family caregivers. Secondary Aims: 1. Establish the initial efficacy of the yoga program in patients and their caregivers regarding quality of life (QOL) outcomes (i.e., fatigue, sleep disturbance, depressive symptoms, and overall QOL) and objective performance outcomes (i.e, sit to stand test and grip strength).
Research Team
Kathrin Milbury, MA,PHD
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for adults over 18 with head and neck cancer who are about to undergo at least 4 weeks of radiotherapy. They must be able to consent, have a performance status of 2 or lower, speak English, and not practice yoga regularly before diagnosis. A family caregiver willing to join the yoga sessions is also required.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Dyadic Yoga Intervention (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Dr. Peter WT Pisters
M.D. Anderson Cancer Center
Chief Executive Officer since 2017
MD from University of Western Ontario
Dr. Jeffrey E. Lee
M.D. Anderson Cancer Center
Chief Medical Officer
MD from Stanford University School of Medicine